Norway’s commitment to ensuring the efficient integration of new health technologies is underscored by its national framework known as the “New Methods” framework. This framework mandates a rigorous evaluation process for all innovations before they receive funding within the specialist health service.
In a significant development in September 2023, the Ordering Forum for “New Methods” extended an invitation to stakeholders interested in magnetic resonance-guided high-intensity focused ultrasound (MRgFUS). This innovative technology has applications in treating intracranial tumors, neurodegenerative diseases, and managing pain related to bone metastases.
The Ordering Forum has set a deadline of October 31, 2023, for the submission of pertinent information regarding MRgFUS. Following this, a critical decision-making juncture is scheduled for November 20, 2023, during which the Ordering Forum will determine whether MRgFUS warrants further evaluation at the national level.
This update is just one of the 300 market access news items compiled by our dedicated team through our subscription services, “HTA Alerts” and “Reimbursement Alerts.” These services offer comprehensive coverage of market access developments in Europe (reimbursement news) and globally (HTA news). To stay informed about developments that specifically concern your products, consider accessing our paid subscription services or reach out to us for a free, no-obligation three-month trial.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
